American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the fourth quarter and year ended December 31, 2013.
Net sales in the fourth quarter of 2013 were $2,133,000 compared to $2,302,000 in the fourth quarter of 2012, a decrease of 7.3%. The Company attributes the sales decline in the fourth quarter to the inability to sell its oral fluid products in the workplace market (due to the unexpected not substantially equivalent determination by FDA in November 2013).
Help employers find you! Check out all the jobs and post your resume.
